Literature DB >> 8557040

Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.

B H Ye1, S Chaganti, C C Chang, H Niu, P Corradini, R S Chaganti, R Dalla-Favera.   

Abstract

The BCL6 gene codes for a zinc-finger transcription factor and is involved in chromosomal rearrangements in 30-40% of diffuse large-cell lymphoma (DLCL). These rearrangements cluster within the 5' regulatory region of BCL6 spanning its first non-coding exon. To determine the functional consequences of these alterations, we have analyzed the structure of the rearranged BCL6 alleles and their corresponding RNA and protein species in two DLCL biopsies and one tumor cell line which carried the t(3;14)(q27;q32) translocation involving the BCL6 and immunoglobulin heavy-chain (IgH) loci. In all three cases, the breakpoints were mapped within the IgH switch region and the BCL6 first intron, leading to the juxtaposition of part of the IgH locus upstream and in the same transcriptional orientation to the BCL6 coding exons. An analysis of cDNA clones showed that these recombinations generate chimeric IgH-BCL6 transcripts which initiated from IgH germline transcript promoters (I mu or I gamma 3), but retain a normal BCL6 coding domain. In the tumor cell line, the chimeric I gamma 3-BCL6 allele, but not the germline BCL6 gene, was transcriptionally active and produced a normal BCL6 protein. These findings indicate that t(3;14) translocations alter BCL6 expression by promoter substitution and imply that the consequence of these alterations is the deregulated expression of a normal BCL6 protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557040      PMCID: PMC394745          DOI: 10.1002/j.1460-2075.1995.tb00311.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

Review 1.  Bcl-2 initiates a new category of oncogenes: regulators of cell death.

Authors:  S J Korsmeyer
Journal:  Blood       Date:  1992-08-15       Impact factor: 22.113

2.  The Drosophila Broad-Complex encodes a family of related proteins containing zinc fingers.

Authors:  P R DiBello; D A Withers; C A Bayer; J W Fristrom; G M Guild
Journal:  Genetics       Date:  1991-10       Impact factor: 4.562

3.  Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes.

Authors:  J V Ravetch; U Siebenlist; S Korsmeyer; T Waldmann; P Leder
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

4.  LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas.

Authors:  J P Kerckaert; C Deweindt; H Tilly; S Quief; G Lecocq; C Bastard
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

5.  Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma.

Authors:  B H Ye; P H Rao; R S Chaganti; R Dalla-Favera
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

Review 6.  Mechanism and regulation of immunoglobulin isotype switching.

Authors:  R L Coffman; D A Lebman; P Rothman
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

7.  Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins.

Authors:  M Numoto; O Niwa; J Kaplan; K K Wong; K Merrell; K Kamiya; K Yanagihara; K Calame
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

8.  Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.

Authors:  P D Aplan; D P Lombardi; G H Reaman; H N Sather; G D Hammond; I R Kirsch
Journal:  Blood       Date:  1992-03-01       Impact factor: 22.113

9.  Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas.

Authors:  B W Baron; G Nucifora; N McCabe; R Espinosa; M M Le Beau; T W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

10.  Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia.

Authors:  Z Chen; N J Brand; A Chen; S J Chen; J H Tong; Z Y Wang; S Waxman; A Zelent
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  61 in total

1.  Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas.

Authors:  Xing Wang; Zhiping Li; Akira Naganuma; B Hilda Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-29       Impact factor: 11.205

2.  Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.

Authors:  Akiko Miyagi Maeshima; Hirokazu Taniguchi; Suguru Fukuhara; Noriyuki Morikawa; Wataru Munakata; Dai Maruyama; Sung-Won Kim; Takashi Watanabe; Yukio Kobayashi; Kensei Tobinai; Hitoshi Tsuda
Journal:  Cancer Sci       Date:  2012-08-14       Impact factor: 6.716

3.  BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells.

Authors:  Himabindu Ramachandrareddy; Alyssa Bouska; Yulei Shen; Ming Ji; Angie Rizzino; Wing C Chan; Timothy W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

4.  BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.

Authors:  C C Chang; B H Ye; R S Chaganti; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

5.  Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation.

Authors:  Xuwei Yang; Koutetsu Lee; Jonathan Said; Xun Gong; Ke Zhang
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

Review 6.  Common mechanisms for the regulation of B cell differentiation and transformation by the transcriptional repressor protein BCL-6.

Authors:  Saritha Kusam; Alexander Dent
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

7.  Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.

Authors:  J Iqbal; T C Greiner; K Patel; B J Dave; L Smith; J Ji; G Wright; W G Sanger; D L Pickering; S Jain; D E Horsman; Y Shen; K Fu; D D Weisenburger; C P Hans; E Campo; R D Gascoyne; A Rosenwald; E S Jaffe; J Delabie; L Rimsza; G Ott; H K Müller-Hermelink; J M Connors; J M Vose; T McKeithan; L M Staudt; W C Chan
Journal:  Leukemia       Date:  2007-07-12       Impact factor: 11.528

8.  Structure of the wild-type human BCL6 POZ domain.

Authors:  Mark A Stead; Gareth O Rosbrook; Jonathan M Hadden; Chi H Trinh; Stephen B Carr; Stephanie C Wright
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-11-28

9.  BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma.

Authors:  Masumichi Saito; Urban Novak; Erich Piovan; Katia Basso; Pavel Sumazin; Christof Schneider; Marta Crespo; Qiong Shen; Govind Bhagat; Andrea Califano; Amy Chadburn; Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-23       Impact factor: 11.205

10.  Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells.

Authors:  Katia Basso; Masumichi Saito; Pavel Sumazin; Adam A Margolin; Kai Wang; Wei-Keat Lim; Yukiko Kitagawa; Christof Schneider; Mariano J Alvarez; Andrea Califano; Riccardo Dalla-Favera
Journal:  Blood       Date:  2009-12-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.